AlphaYouCD
Insider selling
Chris Degnan sold $81K of UroGen Pharma Ltd. (URGN) stock
Chris Degnan, Chief Financial Officer of UroGen Pharma Ltd. (URGN), sold 2,202 shares of URGN stock worth $81K, per an SEC Form 4 filed Oct 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 8, 2026, 1 day before it was made public.
URGN has moved -0.4% since the trade date, from $36.98 to $36.83 (Oct 9, 2026 close).
- Traded
- Oct 8, 2026
- Disclosed
- Oct 9, 2026
- Filing delay
- 1 day
- Price since
- -0.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More URGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.